Duopharma Biotech Bhd (XKLS:7148) Moat Score: 0/10 (As of Jul. 05, 2026)


XKLS:7148 Duopharma Biotech Bhd XKLS:7148
83 GF Score
Price RM1.24
GF Value RM1.53
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Duopharma Biotech Bhd Moat Score?

Duopharma Biotech Bhd has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Duopharma Biotech Bhd has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Duopharma Biotech Bhd might have No Moat - No discernible moat.

Duopharma Biotech Bhd  (XKLS:7148) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Duopharma Biotech Bhd Moat Score Related Terms

XKLS:7148
83GF Score
Duopharma Biotech Bhd XKLS:7148
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Duopharma Biotech Bhd (XKLS:7148) Overvalued in 2026?

Based on GuruFocus' analysis, Duopharma Biotech Bhd stock appears to be undervalued. The current stock price of RM1.24 is trading 19% below its estimated GF Value™ of RM1.53. GuruFocus considers Duopharma Biotech Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:7148:

  • Moat Score: 0
  • GF Value™: RM1.53 vs. price of RM1.24 (19% below fair value)
  • GF Score™: 83/100 with 4 warning signs

No single metric tells the full story. See the XKLS:7148 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Duopharma Biotech Bhd Business Description

Address Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, SGR, MYS, 41200
Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. The company develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines. Geographically, the company generates the majority of its revenue from Malaysia.
83GF Score

Get the complete analysis for XKLS:7148

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM1.24
Price
RM1.53
GF Value